ASGCT: The Home of Cell and Gene Therapy

(3:32)

Welcome to ASGCT: Who We Are and What We Do

(2:38)

What's it Like to Attend the ASGCT Annual Meeting?

(4:7)

ASGCT 2022 Presentation Preview

(2:24)

Welcome to ASGCT: Become a Member

(2:21)

Around the World: Australasian Gene and Cell Therapy Society (AGCTS)

(56:13)

Gene Editing Technologies: Transforming Rare Disease Care

(56:46)

Lunch \u0026 Learn: Diving into Preclinical Studies

(1:1:8)

AAV Vector Manufacturing and Analytics

(33:36)

Reducing the Immunogenicity of AAV through Engineering the Vector - George Church

(18:36)

Gene-editing Technologies: Powerful Tools Rewriting the Code of Life

(52:59)

AAV Integration Roundtable

(6:52:56)

Basics of AAV Gene Therapy

(30:1econd)

Lunch \u0026 Learn: How AAV Vectors Are Made

(1:3:21)

ASJ JC Aug 2021

(1:12:39)

CRISPR Editing and AAV Integration in the Brain with Drs. Beverly Davidson and Bryan Simpson—The ...

(36:22)

Policy and Advocacy Shorts with Federico Mingozzi, PhD

(48)

Forge at ASGCT 2024 Wrap Up

(1:37)

An Explosive Year for Gene Therapy with ASGCT President Paula Cannon

(4:40)

ASGCT 2024 Abstract Highlights with Chris Leidli, Emily Walsh Martin, and Lynnea Olivarez

(45:1econd)

Dr. Paloma Giangrande 2013 ASGCT ONI Award Recipient

(6:21)

ASGCT Community Quick Takes: Genetic Testing and Clinical Trial Eligibility

(25:36)

Completing Your Profile and Networking at #ASGCT21

(1:27)

Policy and Advocacy Shorts with Keith Wonnacott, PhD

(40)

Policy and Advocacy Shorts with Katy Spink, PhD

(31)

2022 ISSCR/ASGCT Madison International Symposium

(1:2)

ASGCT 2024 Poster Presentations

(1:4)

ASGCT 2023 Presentation Overview

(1:35)

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

(55:21)